Michael Makris։ A New NEJM Paper Shows Results for Mim8, a Drug Similar to Emicizumab
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at University of Sheffield, shared a post on LinkedIn about a recent article by Maria Elisa Mancuso et al, published in The New England Journal of Medicine (NEJM), adding։
”The Mim8 results paper was published today in the New England Journal of Medicine.
Mim8 works in the same way and is a direct competitor to emicizumab (Hemlibra).
The introduction of emicizumab has been the most impactful change in hemophilia care in the last 20-25 years.
Both Mim8 and emicizumab are bispecific antibodies. Is one better than the other in terms of efficacy? Only a randomised trial will tell us this, but nobody will do such a trial. I expect there will be lots of papers comparing the two products in a non-randomised way, with all the limitations that they bring.
In most countries, the introduction of a second similar drug will result in competition and lower prices, but I doubt this will be the case in the US.
The PDF of the paper is behind a paywall, but here is the graphical summary.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg
Other posts featuring Michael Makris on Hemostasis Today.
-
May 1, 2026, 14:32Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
-
May 1, 2026, 14:16Violeta Jardin: Precision-Guided Systemic Thrombolysis in High-Risk PE
-
May 1, 2026, 14:11Austin Manning: Mercy San Juan Medical Center’s Role in Kristen’s Stroke Recovery and Hope
-
May 1, 2026, 14:01Andrew M. Ibrahim: AI in Stroke Care and the Evidence Gap in Healthcare Delivery
-
May 1, 2026, 13:55Join the ISBT Webinar on AI in Transfusion Medicine
-
May 1, 2026, 13:46Nicole W.: Deeply Moved to Receive the 2026 Office of Patient Experience Interpreter Services Partner in Excellence Award
-
May 1, 2026, 13:36Andrea Goldsmith: Advancing Stroke Care Through Stony Brook Medicine’s Mobile Stroke Unit Program
-
May 1, 2026, 13:36Shuaibing Jiang: Synthetic Clot Formation Through Click Chemistry for Instant Bleeding Control
-
May 1, 2026, 13:26Omid Seidizadeh: von Willebrand Disease May Be More Common than Previously Thought